A generation ago, the market for vaccines worked well in wealthy countries – if you wanted to be immunized against a whole range of diseases, you could – but the system did not work that well for developing nations as they do not have the resources to make immunization available to everyone. With the COVID 19 pandemic the developed world has seen firsthand, the impact and disruption a virus, without a vaccine, can have on the economy, supply chain and day to day life. In developing countries, COVID is one more deadly virus add to the list of viruses they can’t afford to treat. Without low cost vaccines the impact to developing countries can be more devastating. Some of the leading causes of death in developing countries are HIV/AIDS, Malaria and Tuberculosis all can be solved thru affordable low cost immunization. The battle to lift the world’s poorest populations out of hunger, extreme poverty and disease is ongoing. In developed countries, low cost vaccines can help to ensure that all people, especially those people with the fewest resources, have access to the immunizations they need to survive. Speakers from the Bill and Melinda Gates Foundation, IPS-Integrated Project Services, LLC and Rommalag will discuss various programs, challenges and technologies to deploy low cost, distributed vaccine manufacturing capabilities in developing countries.